Atlas Trials

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Clinical trial NCT03073694 · UNKNOWN

Trial details

NCT number
NCT03073694
Sponsor
University of Kansas Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer, AppendicealColoRectal Cancer
Start date
2017-07-14
Primary completion
2024-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.